Academic research on Johrei
Medical Research on Johrei
In 1981, Teruyuki Tada, the founding director of Reimei Church, began conducting medical research on Johrei, starting with performing Johrei on lung cancer patients at the Roswell Park Memorial Institute in Buffalo, New York, USA. Subsequently, in August 1998, the NPO Johrei Institute was established in California, USA. In collaboration with physicians and medical researchers, we have scientifically verified the efficacy of Johrei in treating various illnesses and diseases. We have presented our findings at academic conferences and in academic papers.Some of the research conducted to date has been featured as "Johrei therapy" in “Bonica's Management of Pain*” (5th Edition), which healthcare professionals worldwide refer to as the “textbook of pain treatment.”
※A globally renowned classic that systematically compiles the understanding and treatment of pain. Integrating the latest scientific findings with clinical practice, it is positioned as the “standard” for pain treatment in healthcare settings.
please click here
Bonica's Management of PainGasiorowska, A., et al. (2009) "Clinical trial: the effect of Johrei on symptoms of patients with functional chest pain." Alimentary Pharmacology & Therapeutics, 29: 126–134.
Clinical trial: the effect of Johrei on symptoms of patients with functional chest pain. (Gasiorowska, et al., 2009) In this trial, Johrei was performed on patients with functional chest pain (FCP) ; recurrent episodes of retrosternal pain lacking cardiac or esophageal abnormality. The efficacy of Johrei as compared to wait-list controls in improving symptoms of FCP was demonstrated. No serious side effects were reported. These findings were published in 2009 in the academic journal "Alimentary Pharmacology & Therapeutics", Volume 29 (pp. 126–134).
Background
The cause of functional chest pain is difficult to determine by examination, and treatment other than conventional medication is expected. Jorei is a non-contact therapy. Its mechanism is not scientifically proven, and research on its effectiveness is still limited.
Aim
To determine whether Johrei therapy improves chest pain symptoms (frequency and severity) in patients with FCP compared with a wait-list control.
Methods
Patients with FCP were enrolled after exclusion of cardiac causes and confirmation of normal upper endoscopy, 24-hour pH monitoring, and esophageal manometry. Ptients were randomized into: Johrei group: 21 patients (18 Johrei sessions over 6 weeks) Wait-list group: 18 patients (no treatment during study period) Chest pain was evaluated using a symptom intensity score (frequency × severity).
Results
Johrei group showed significant improvement (decrease to approximately one-third on average). However, Wait-list group showed no significant change. No statistically significant differences between groups in health-related QOL, although the Johrei group showed numerically greater improvement. Johrei was well tolerated with no adverse events reported.
Conclusion
This pilot study suggests that Johrei therapy may reduce chest pain symptoms in patients with FCP compared with a wait-list control. Future randomized trials using sham Johrei or supportive care controls are needed to validate these findings and clarify mechanisms.
For more detailed information, please visit here.
research paper pageIf you are interested, please contact us here.
contact pageBuzzetti, R.A., et al. (2013) "Effect of Johrei therapy on sleep in a murine model. " Explore, 9: 100–105.
Effect of Johrei Therapy on Sleep in a Murine Model (Bezzetti, et al., 2013) When Johrei was performed on mice subjected to intermittent sleep interruption, sleep-related brain indicators increased, and sleep efficiency derived from brain waves showed an improvement trend. The superiority of Johrei was demonstrated compared to the sham treatment and control groups. The research findings were published in 2013 in the academic journal "Explore" Volume 9 (pp.100–105).
Background
Sleep deprivation is an underrecognized problem that afflicts our society and can lead to reductions in vitality. Vitality is thought to interact with sleep and can be improved by Johrei therapy.
Aim
The central purpose of this study was to explore the sleep-promoting effects of Johrei in mice subjected to sleep interruption. The exploratory aim of the study was to determine the effect of Johrei on sleep as measured by tissue markers (c-Fos). in the brain and electroencephalography-derived sleep in sleep-interrupted mice when compared with control mice.
Methods
45 male C57BL/6J mice randomly assigned to five groups :
1. Johrei therapy alone
2. Sham control (presence of practitioner only)
3. True control (no exposure)
4. Sleep interruption
5. Sleep interruption + Johrei therapy
The sleep-promoting effects were evaluated using c-Fos–positive neurons in the medial preoptic area (marker of recent sleep) and EEG-derived sleep efficiency (percentage of sleep relative to baseline).
Results
Brain Sleep Marker (c-Fos)
Sleep-interrupted mice showed very low c-Fos expression (2.4%).
Sleep-interrupted mice with Johrei showed much higher c-Fos (14.5%; P < .0001).
EEG Sleep Efficiency In sleep-interrupted mice:Johrei improved sleep efficiency (median 115%) vs. sleep interruption alone (median 89%)
Conclusion
Johrei therapy improved sleep in sleep-interrupted mice, demonstrated by:
•Higher c-Fos levels in sleep-related brain regions
•Better EEG-assessed sleep efficiency
Future studies should evaluate whether Johrei can similarly improve sleep in humans, especially those suffering from insomnia or chronic sleep disruption.
For more detailed information, please visit here.
research paper pageIf you are interested, please contact us here.
contact page
Please describe your inquiry and provide us with your contact information.
Contact